These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37707564)

  • 21. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [THE NEW CONCEPT OF COMBINED USE OF EXTRACORPOREAL BLOOD CORRECTION IN COMPLEX INTENSIVE THERAPY OF SEVERE SEPSIS IN PATIENTS AFTER CARDIAC SURGERY].
    Yarustovsky MB; Abramyan MV; Krotenko NP; Popov DA; Plyusch MG; Gordeev SL; Rogalskaya EA
    Anesteziol Reanimatol; 2015; 60(5):75-80. PubMed ID: 27029079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoperfusion in COVID-19.
    Lertussavavivat T; Srisawat N
    Contrib Nephrol; 2023; 200():192-200. PubMed ID: 37263252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemoadsorption for blood purification-incomparability of clinically available procedures].
    Krenn CG; Steltzer H
    Med Klin Intensivmed Notfmed; 2021 Jun; 116(5):449-453. PubMed ID: 32583037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo.
    Jansen A; Waalders NJB; van Lier DPT; Kox M; Pickkers P
    Crit Care; 2023 Mar; 27(1):117. PubMed ID: 36945034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarities, Differences, and Potential Synergies in the Mechanism of Action of Albumin Dialysis Using the MARS Albumin Dialysis Device and the CytoSorb Hemoperfusion Device in the Treatment of Liver Failure.
    Dominik A; Stange J
    Blood Purif; 2021; 50(1):119-128. PubMed ID: 32615564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal Replacement Techniques in Septic Shock.
    Hellman T; Uusalo P; Järvisalo MJ
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Hemoperfusion With CytoSorb Associated With Continuous Kidney Replacement Therapy on Renal Outcome in Critically III Children With Septic Shock.
    Bottari G; Lorenzetti G; Severini F; Cappoli A; Cecchetti C; Guzzo I
    Front Pediatr; 2021; 9():718049. PubMed ID: 34504817
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of Continuous Renal Replacement Therapy with the oXiris Hemofilter on Critically Ill Patients: A Narrative Review.
    Li Y; Sun P; Chang K; Yang M; Deng N; Chen S; Su B
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients.
    Peng JY; Li L; Zhao X; Ding F; Hou X; Peng Z
    Blood Purif; 2022; 51(5):410-416. PubMed ID: 34407530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective LPS Adsorption Using Polymyxin B-Immobilized Fiber Cartridges in Sepsis Patients Following Cardiac Surgery.
    Yaroustovsky M; Abramyan M; Komardina E; Nazarova H; Popov D; Plyushch M; Soldatkina A; Rogalskaya E
    Shock; 2018 Jun; 49(6):658-666. PubMed ID: 28991050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb
    Singh YP; Chhabra SC; Lashkari K; Taneja A; Garg A; Chandra A; Chhabra M; Singh GP; Jain S
    Int J Artif Organs; 2020 Jun; 43(6):372-378. PubMed ID: 31868078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoadsorption treatment with CytoSorb
    Träger K; Skrabal C; Fischer G; Schroeder J; Marenski L; Liebold A; Reinelt H; Datzmann T
    Int J Artif Organs; 2020 Jun; 43(6):422-429. PubMed ID: 31868089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience.
    Calabrò MG; Febres D; Recca G; Lembo R; Fominskiy E; Scandroglio AM; Zangrillo A; Pappalardo F
    Artif Organs; 2019 Feb; 43(2):189-194. PubMed ID: 30156308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
    Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
    Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the CytoSorb
    Nierhaus A; Morales J; Wendt D; Scheier J; Gutzler D; Jarczak D; Born F; Hagl C; Deliargyris E; Mehta Y
    Minim Invasive Ther Allied Technol; 2022 Oct; 31(7):1058-1065. PubMed ID: 35913784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbinda Affinity Blood Filter -a device approved for the treatment of COVID-19 patients.
    Seffer MT; Martens-Lobenhoffer J; Schmidt JJ; Eden G; Bode-Böger SM; Kielstein JT
    Ther Apher Dial; 2021 Apr; 25(2):237-241. PubMed ID: 32558210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful Treatment of Severe Digitoxin Intoxication with CytoSorb® Hemoadsorption.
    Breuer TGK; Quast DR; Wiciok S; Labedi A; Ellrichmann G
    Blood Purif; 2021; 50(1):137-140. PubMed ID: 32937619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review.
    Honore PM; Jacobs R; Joannes-Boyau O; De Regt J; De Waele E; van Gorp V; Boer W; Verfaillie L; Spapen HD
    ASAIO J; 2013; 59(2):99-106. PubMed ID: 23438770
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.